RFC4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.792800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.589200E-01
Normal-vs-Stage2
8.789600E-01
Normal-vs-Stage3
3.689000E-01
Normal-vs-Stage4
6.365800E-01
Stage1-vs-Stage2
3.301600E-01
Stage1-vs-Stage3
6.634000E-01
Stage1-vs-Stage4
7.811400E-01
Stage2-vs-Stage3
2.417000E-01
Stage2-vs-Stage4
5.890000E-01
Stage3-vs-Stage4
6.170400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.234000E-01
Normal-vs-AfricanAmerican
5.262000E-01
Normal-vs-Asian
5.374600E-01
Caucasian-vs-AfricanAmerican
4.394800E-01
Caucasian-vs-Asian
5.999000E-01
AfricanAmerican-vs-Asian
6.748600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.586200E-01
Normal-vs-Female
9.010200E-01
Male-vs-Female
3.787800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.034600E-01
Normal-vs-Age(41-60Yrs)
9.885200E-01
Normal-vs-Age(61-80Yrs)
6.526400E-01
Normal-vs-Age(81-100Yrs)
9.724000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.613800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.047400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.555240E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.021600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.323400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.452600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.437800E-01
Normal-vs-Daily Drinker
5.634200E-01
Normal-vs-Weekly Drinker
9.758600E-01
Normal-vs-Occasional Drinker
9.660000E-01
Normal-vs-Social Drinker
8.853600E-01
Non Drinker-vs-Daily Drinker
7.769000E-01
Non Drinker-vs-Weekly Drinker
5.338800E-01
Non Drinker-vs-Occasional Drinker
4.391200E-01
Non Drinker-vs-Social Drinker
3.736400E-01
Daily Drinker-vs-Weekly Drinker
4.399400E-01
Daily Drinker-vs-Occasional Drinker
2.496600E-01
Daily Drinker-vs-Social Drinker
2.972400E-01
Weekly Drinker-vs-Occasional Drinker
9.985200E-01
Weekly Drinker-vs-Social Drinker
8.517000E-01
Occasional Drinker-vs-Social Drinker
8.106600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.618000E-01
Normal-vs-Grade 2
7.370600E-01
Normal-vs-Grade 3
8.123600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.137500E-03
Grade 1-vs-Grade 3
9.81519999999625E-05
Grade 1-vs-Grade 4
6.618000E-01
Grade 2-vs-Grade 3
2.936300E-02
Grade 2-vs-Grade 4
7.370600E-01
Grade 3-vs-Grade 4
8.123600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.421400E-01
Normal-vs-NonDiabetic
8.731600E-01
Diabetic-vs-NonDiabetic
2.402400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.740000E-01
Normal-vs-NoPancreatitis
7.802800E-01
Pancreatitis-vs-NoPancreatitis
3.145000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.885600E-01
Normal-vs-N1
8.649200E-01
N0-vs-N1
3.634200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.601400E-01
Normal-vs-TP53-NonMutant
6.672800E-01
TP53-Mutant-vs-TP53-NonMutant
2.38929999996085E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
